Company: ARTL
Filing Date: 2025-07-18
Form Type: 424B5
Source: 0001640334-25-001239
Chunk: 28

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-07-18
Form: 424B5
Chunk 28
---
 sale of our shares of common stock on our behalf, Lafferty will be deemed to be an “underwriter” within the meaning of the Securities Act, and the compensation Lafferty will be deemed to be underwriting commissions or discounts. We have agreed to indemnify Lafferty against certain civil liabilities, including liabilities under the Securities Act. We have also agreed to contribute to payments Lafferty may be required to make in respect of such liabilities. Lafferty will not engage in any market making activities involving shares of our common stock while the offering is ongoing under this prospectus if such activity would be prohibited under Regulation M or other anti-manipulation rules under the Securities Act. As our sales agent, Lafferty will not engage in any transactions that stabilizes shares of our common stock.

The offering of our shares of common stock pursuant to the Sales Agreement will terminate upon the termination of the Sales Agreement as permitted therein. Either party may terminate the Sales Agreement at any time upon five business days’ prior written notice to the other party.

Lafferty and its affiliates may in the future provide various investment banking, commercial banking, financial advisory and other financial services for us and our affiliates, for which services they may in the future receive customary fees. In the course of its business, Lafferty may actively trade our securities for its own account or for the accounts of customers, and, accordingly, Lafferty may at any time hold long or short positions in such securities.

This prospectus supplement and the accompanying prospectus in electronic format may be made available on a website maintained by Lafferty, and Lafferty may distribute the prospectus supplement and the accompanying prospectus electronically.

The transfer agent and registrar for our common stock is Equiniti Trust Company, LLC. The transfer agent’s principal business address is 28 Liberty Street, 53rd Floor, New York, NY 10005.

Our common stock is listed on The Nasdaq Capital Market under the symbol “ARTL.”

| S-22 |

<div align='center'>LEGAL MATTERS</div>

The validity of the common stock offered by this prospectus supplement and the accompanying prospectus will be passed upon for us by Fennemore Craig, P.C., Reno, Nevada. Ellenoff Grossman & Schole LLP, New York, New York, is counsel for Lafferty in connection with this offering.

<div align='center'>EXPERTS</div>

The consolidated financial statements of Artelo Biosciences, Inc. incorporated in this prospectus